Literature DB >> 2307273

Kaposi's sarcoma: retrospective study of 67 cases with the classical form.

R Friedman-Birnbaum1, S Weltfriend, I Katz.   

Abstract

The records of 67 Israeli patients with classical Kaposi's sarcoma treated at Rambam Medical Center were analyzed retrospectively for clinical and laboratory data. As expected, all except 1 patient were of Jewish origin. There was a male predominance with a ratio of 2.2:1. The age of onset was mostly during the 5th to 7th decades of life. The course of the disease was usually slow and indolent. As has been already noted, we found a higher frequency of diabetes mellitus (16.4%). Although a high frequency of second primary malignancy was seen in our patients, this was less so than that described in an American series, 15% as compared to 37%, respectively. The most frequent second malignancy was that of the lymphoreticular system. No serologic evidence for an association with types of herpes virus infection has been found. No alterations in humoral and cellular immunity were demonstrated. These data show similar clinical findings with those described in other series, besides the lower frequency of a second primary malignancy. Some discordance with that described before concerning the relationship with cytomegalovirus infection and T cells subsets was also noted.

Entities:  

Mesh:

Year:  1990        PMID: 2307273     DOI: 10.1159/000247978

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  7 in total

Review 1.  Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.

Authors:  P Casoli; B Tumiati
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

2.  Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 Gy versus 6 Gy.

Authors:  Ferah Yildiz; Mine Genc; Serap Akyurek; Mustafa Cengiz; Enis Ozyar; Ugur Selek; I Lale Atahan
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

3.  Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.

Authors:  Patrick A Carroll; Heidi L Kenerson; Raymond S Yeung; Michael Lagunoff
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

4.  Kaposi Sarcoma in a Non HIV Patient.

Authors:  Rafi A Jan; Parvaiz A Koul; Manzoor Ahmed; Sonaullah Shah; Showkat A Mufti; Fayaz A War
Journal:  Int J Health Sci (Qassim)       Date:  2008-07

Review 5.  Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

Authors:  Kwun Wah Wen; Blossom Damania
Journal:  Cancer Lett       Date:  2009-08-03       Impact factor: 8.679

6.  Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic.

Authors:  H Hjalgrim; M Melbye; E Pukkala; F Langmark; M Frisch; M Dictor; A Ekbom
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.

Authors:  Rui Sun; Xiaohua Tan; Xing Wang; Xiaodong Wang; Lei Yang; Erle S Robertson; Ke Lan
Journal:  PLoS Pathog       Date:  2017-01-24       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.